A Randomized Phase II Study of the Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy and 5FU or Capecitabine With and Without Zometa in Patients With Locally Advanced Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil (Primary) ; Zoledronic acid (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Sep 2017 Planned End Date changed from 16 Sep 2019 to 16 Sep 2020.
- 23 Sep 2017 Planned End Date changed from 1 Sep 2020 to 16 Sep 2019.